ECO Animal Health
Chris Wilks is the Chief Financial Officer at ECO ANIMAL HEALTH GROUP PLC since September 2019. Previously, Chris held the position of Non Executive Director at Kromek Group plc since September 2017. Prior to that, Chris served as Finance Director/CFO at Signum Technology Limited from March 2012 to March 2019 and as Group Finance Director at Sondex plc from May 1997 to February 2008. Chris started their career at ernst & young from 1986 to 1994, initially serving as an Articles, Audit, Corporate Finance Manager. Chris holds a degree in FCA from ICAEW and a BSc Hons in Applied Physics and Electronics from Durham University.
This person is not in any offices
ECO Animal Health
ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline. Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide. Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.